Baxter International has acquired Baxa, the US-based developer of pharmacy technology, for a cash consideration of $380m.

Baxter Medical Products develops, manufactures and markets products used in the delivery of fluids and drugs to patients.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Baxter Medical Products business president Robert Davis said the transaction will allow Baxter to provide a broader range of solutions for the safe preparation and delivery of IV medications.

"We believe Baxa’s expertise in safely preparing IV and oral liquid medications, and their shared commitment toward improving patient care through innovative drug preparation and delivery technology, will benefit patients around the world," Davis added.

Baxter’s product portfolio includes ExactaMix, ExactaMed syringes, NeoThrive enteral feeding system, enteral syringes and accessories and the DoseEdge pharmacy workflow manager for managing IV and oral dose preparation activities.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.